GEMITERO gemcitabine (as hydrochloride) 1 g powder for injection vial

Țară: Australia

Limbă: engleză

Sursă: Department of Health (Therapeutic Goods Administration)

Ingredient activ:

gemcitabine hydrochloride, Quantity: 1138 mg

Disponibil de la:

Hetero Australia Pty Ltd

INN (nume internaţional):

Gemcitabine hydrochloride

Forma farmaceutică:

Injection, powder for

Compoziție:

Excipient Ingredients: mannitol; sodium acetate trihydrate; sodium hydroxide

Calea de administrare:

Intravenous Infusion

Unități în pachet:

1 vial

Tip de prescriptie medicala:

(S4) Prescription Only Medicine

Indicații terapeutice:

Gemcitabine is indicated for treatment of patients with locally advanced or metastatic non- small cell lung cancer.,Gemcitabine is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. Gemcitabine is also indicated for patients with 5-FU refractory pancreatic cancer.,Gemcitabine, alone or in combination with cisplatin, is indicated for treatment of patients with bladder cancer.,Gemcitabine, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated.,Gemcitabine, in combination with carboplatin, is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma, who have relapsed > 6 months following platinum? based therapy

Rezumat produs:

Visual Identification: White to off-white lyophilised powder to be reconstituted for intravenous use.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Statutul autorizaţiei:

Licence status A

Data de autorizare:

2015-03-03